Norvask

Quick links to important sections

Norvask

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Norvask

What is Norvasc? Defining the Therapeutic Entity

Norvasc is the proprietary brand name for a widely utilized prescription medication whose active component is the chemical compound Amlodipine. This pharmaceutical preparation is administered as an oral tablet, placing it in the category of medicines that exert systemic effects after being swallowed. The medication is categorized as a Calcium Channel Blocker (CCB), a class of drugs primarily used to manage cardiovascular conditions.

Property Description
Active ingredient Amlodipine (Amlodipine Besylate salt)
Form Oral tablet
Pharmacological class Calcium Channel Blocker (Dihydropyridine)
General purpose Regulates blood pressure and improves blood flow to the heart
Origin Synthetic compound

Amlodipine’s Pharmacological Class and Origin

The active substance, Amlodipine, belongs specifically to the dihydropyridine subclass of Calcium Channel Blockers. This classification is assigned because the drug primarily acts on the peripheral and coronary blood vessels (vascular selectivity). The compound is confirmed to be a synthetic compound, created through chemical synthesis rather than being derived from natural sources.

Norvasc is distinguished as a prescription-only (Rx) medication and is provided as a single-ingredient product (monotherapy), containing Amlodipine Besylate alongside inactive excipients. The compound's structural design allows for a sustained, long-acting profile, a characteristic recognized for supporting consistent once-daily administration.


General Purpose: The Cardiovascular Action of Norvasc

Amlodipine’s general purpose is to promote vasodilation, which is the relaxation and widening of blood vessels throughout the body. The mechanism involves selectively inhibiting the influx of calcium ions into the arterial smooth muscle cells, which prevents contraction and encourages relaxation.

This action forms the basis of the drug's core benefit: it is widely used to manage high blood pressure and effectively regulates blood pressure and helps improve the supply of oxygen-rich blood to the heart muscle. By reducing the overall resistance in the arterial system, Amlodipine decreases the workload on the heart and supports consistent, healthy cardiovascular function.

What side effects are possible with Norvask?

Possible Side Effects and Safety Information

Norvasc (amlodipine besylate) is associated with a defined safety profile, categorized by frequency and system-organ class based on official regulatory documents. The most common side effects reported are edema (swelling, particularly of the ankles or legs) and headache, both of which have been shown to be dose-related in clinical trials.

Other adverse reactions frequently observed include somnolence (drowsiness), dizziness, fatigue, nausea, abdominal pain, palpitations, and flushing (a hot or warm feeling in the face).


Serious and Clinically Significant Reactions

Although rare, certain clinically significant adverse reactions have been documented:

  • Increased Angina or Myocardial Infarction: In patients with severe obstructive coronary artery disease, worsening chest pain (angina) or an acute myocardial infarction can develop when starting or increasing the amlodipine dose.
  • Symptomatic Hypotension: Low blood pressure causing symptoms like lightheadedness is possible, particularly in patients with severe aortic stenosis.
  • Hypersensitivity: Very rare but serious reactions include angioedema, erythema multiforme, and hepatitis.

Safety Considerations and Restrictions

Contraindications include known hypersensitivity to amlodipine or dihydropyridine derivatives, severe hypotension, and cardiogenic shock. Caution is advised for elderly patients and those with hepatic (liver) impairment due to reduced clearance, potentially necessitating a lower initial dose. A specific restriction is the co-administration of Norvasc with simvastatin, where the simvastatin dose must not exceed 20 mg daily due to an increased risk of myopathy.

Overdose and Emergency Response

Overdose and when to seek help — Official Regulatory Information

The official documentation for Amlodipine (Norvasc) overdose describes exaggerated pharmacological effects, primarily focused on the cardiovascular system due to excessive vasodilation.

Category Documented Manifestations
Common Clinical Signs Dizziness, Fainting (Syncope), Rapid Heartbeat (Reflex Tachycardia)
Severe Physiological States Profound Hypotension, Bradycardia (slowed heart rate)

An acute overdose can progress rapidly and is considered potentially life-threatening. Severe outcomes include a state of shock and collapse, and the onset of seizure.

Required Emergency Actions

Regulatory guidance mandates seeking immediate medical attention for any suspected overdose. Emergency Services or the Poison Control Helpline must be contacted immediately. Urgent medical intervention is explicitly required if the person has collapsed, experiences trouble breathing, has had a seizure, or cannot be awakened.

Official Management and Monitoring

Management is strictly symptomatic and supportive, as no specific antidote is known. Treatment measures may include decontamination procedures like activated charcoal and stabilization using intravenous fluids and supportive medication to address hypotension. Due to the drug's long-acting nature, continuous hospital monitoring, including ECG and vital sign observation, is typically required, often necessitating an overnight hospital stay.

Therapeutic Uses of Norvask

What Norvasc Treats: Main Uses and Benefits

The primary therapeutic role of Norvasc (Amlodipine) is generally defined by its ability to provide supportive relief across several chronic cardiovascular conditions. The medication is commonly used to help manage both symptoms related to heightened physiological activity and conditions marked by increased physiological stress.

In clinical contexts, Norvasc is primarily used in the long-term, sustained management of essential hypertension (high blood pressure) and to control the symptoms of angina pectoris, including both chronic stable angina and vasospastic angina. It is also applied in patients with angiographically documented Coronary Artery Disease (CAD). A key therapeutic benefit is the consistent lowering and regulation of elevated blood pressure and may assist in the reduction of the frequency and severity of painful angina episodes.

The overall purpose is to ease the functional strain on the heart and supports patients during episodes of heightened discomfort by easing distress.

“It is commonly used across domains where additional symptomatic support is needed to assist in the reduction of cardiovascular risks.”


Quick Fact: Relief for Vascular Pressure and Chest Pain

Norvasc assists with managing symptoms related to chronically elevated blood pressure and recurrent chest discomfort due to ischemic heart conditions.

Eligibility and Restrictions for Use

Norvasc (amlodipine) population eligibility rules are strictly defined by regulatory authorities based on hypersensitivity, age, and pre-existing conditions.

Contraindicated Populations

Use of Norvasc is prohibited for patients with a known hypersensitivity to amlodipine or other dihydropyridine derivatives. The medicine is also contraindicated in patients with severe hypotension, cardiogenic shock, obstruction of the left ventricular outflow tract (such as severe aortic stenosis), or haemodynamically unstable heart failure after acute myocardial infarction.

Age-Related Eligibility

Adults are eligible for all labeled indications. For pediatric patients aged 6 to 17 years, use is established for hypertension only. The safety and efficacy of Norvasc are not established for children under 6 years of age.

Conditional Use and Restrictions

Use requires caution in older adults (who often require a lower starting dose) and in patients with hepatic impairment (liver dysfunction) due to reduced drug clearance. While the pharmacokinetics are not significantly affected by renal impairment, caution is advised for patients with certain severe pre-existing heart conditions. During pregnancy or lactation, use is generally restricted and requires weighing the benefit against the potential risk, as officially documented in prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Norvasc (amlodipine) is metabolized by the enzyme CYP3A4, which is the primary basis for its drug interactions.

Interacting Medicines and Products

Interaction Mechanism Interacting Products (Examples) Clinical Effect/Note
Inhibition of CYP3A4 Ketoconazole, Itraconazole, Clarithromycin, Grapefruit/Grapefruit juice Increased plasma concentrations of amlodipine, enhancing the risk of low blood pressure (hypotension). Close monitoring is advised.
Induction of CYP3A4 Rifampicin, St. John's wort (Hypericum perforatum) Decreased plasma concentrations of amlodipine, potentially reducing the blood pressure-lowering effect.
Inhibition by Amlodipine Simvastatin, Ciclosporin, Tacrolimus Increased exposure of the co-administered drug. The dosage of Simvastatin must be limited to 20 mg daily when co-administered with amlodipine. Increased monitoring of Ciclosporin and Tacrolimus blood levels is recommended.
Additive Antihypertensive Effect Thiazide diuretics, ACE inhibitors, Beta-blockers The blood pressure-lowering effect is enhanced. No Norvasc dose adjustment is typically required.

Co-administration with grapefruit or grapefruit juice is not recommended as it may increase amlodipine bioavailability, potentially leading to increased hypotension.

Mechanism of Action

Selective Inhibition of Calcium Channels

Amlodipine, the active pharmaceutical ingredient in Norvasc, functions as a dihydropyridine calcium channel blocker. Its primary action is the selective inhibition of transmembrane influx of calcium ions into vascular smooth muscle cells via voltage-dependent L-type calcium channels. This interaction limits the high intracellular calcium concentration required for the actin-myosin cross-bridging cycle, thereby restricting smooth muscle contraction.

Arterial Vasodilation and Resistance Modulation

The resulting reduction in calcium-mediated contraction within the vasculature triggers vasodilation (widening) of peripheral arteries and arterioles. This physiological consequence is a decrease in total peripheral resistance (also known as afterload). This mechanism influences systemic arterial pressure by modulating the inherent tone and resistance within the peripheral circulation.

️ Regulation of Coronary Vasomotor Tone

Additionally, amlodipine engages mechanisms that attenuate contraction in the smooth muscle of the coronary arteries. By restricting calcium influx, it modifies the molecular signaling that regulates coronary vessel diameter, promoting an altered state of local pathway activity.

Dosage and Administration Information

Official Administration Guidelines for Norvasc

Norvasc (amlodipine) is a prescription medication administered via the oral route, supplied in tablet strengths of 2.5 mg, 5 mg, and 10 mg. The established usage schedule requires administration once daily to maintain sustained plasma concentrations, and the medication may be taken with or without food.


Dosing and Titration Protocol

The standard adult initial dose for approved indications is 5 mg once daily. The dosage is gradually adjusted to a maintenance range of 5 mg to 10 mg, with 10 mg representing the maximum recommended daily dose. The procedural requirement for dosage adjustment dictates that titration must proceed slowly, typically at intervals of 7 to 14 days, allowing sufficient time for the new dose level to reach steady-state before further modification is considered.


Population-Specific Use

Specific starting regimens are detailed for various populations. Small, fragile, or elderly patients, as well as those with hepatic impairment, are typically initiated at a reduced dose of 2.5 mg once daily. In contrast, patients with renal impairment do not generally require a dosage adjustment. For pediatric patients aged 6–17 years with hypertension, the designated dose range is 2.5 mg to 5 mg once daily.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Norvasc


Evidence for Use in Managing High Blood Pressure (Hypertension)

Research for Norvasc (Amlodipine) in the context of managing high blood pressure is based on multiple large-scale clinical investigations. This includes Randomized Controlled Trials (RCTs) and extensive meta-analyses. The studies monitored outcomes reflecting physiological strain or stress, specifically changes in both the systolic and diastolic blood pressure readings over defined time intervals. Long-term studies, some lasting up to five years, also monitored data related to Major Cardiovascular Events, such as the occurrence of stroke or heart attack, and all-cause mortality.

Research examined the findings of amlodipine in comparison to several other established drug classes. Data for children is limited to those aged 6 to 17 years and specific dosage ranges were explored.


Evidence for Use in Chronic Stable and Vasospastic Angina

Evidence related to Amlodipine in the context of chest pain conditions like chronic stable angina and vasospastic angina (Prinzmetal's) comes largely from short- to intermediate-term controlled clinical trials. Researchers monitored outcomes such as the frequency of anginal episodes and functional capacity through standardized exercise tests. Findings highlight changes measured during the study period, such as metrics associated with patient performance during standardized exercise tests.

However, research focusing on chronic stable angina tends to concentrate more on symptom reporting and functional capacity assessments over short periods, meaning there is limited information for long-term outcomes in these specific trials. The evidence for vasospastic angina is more limited, often relying on smaller studies focusing on episodic physiological changes.


Evidence for Use in Coronary Artery Disease (CAD)

Research has also explored Amlodipine in studies of adults with angiographically documented Coronary Artery Disease (CAD), provided they did not have severe heart failure. This evidence is primarily drawn from specific large-scale outcome trials with long-term follow-up. Researchers tracked outcomes reflecting daily functioning, specifically the risk of hospitalization due to angina and the need for subsequent coronary revascularization procedures.

It is critical to understand that the results apply only to the specific populations studied; trials that included patients with more severe heart failure yielded different outcomes regarding mortality and morbidity, which means the findings for the documented CAD group are specific to patients without severe heart failure.

Frequently Asked Questions (FAQ)

Common questions about Norvasc (FAQ)

Q: Why does Norvasc cause swelling (edema) in the lower legs?

The action of amlodipine involves peripheral arterial vasodilation, which means it widens the blood vessels in the body. This effect reduces the resistance to blood flow and lowers blood pressure. Official information indicates that this physiological mechanism contributes to the common side effect of swelling, or edema, in the lower legs.

Q: Do side effects from Norvasc usually improve or go away over time?

According to general patient information for amlodipine, common side effects such as headache, flushing, and swollen ankles may improve or lessen after the initial few days of use. This suggests an initial period of adjustment. Patients can discuss any persistent or bothersome side effects with their healthcare provider.

Q: Is weight gain a reported side effect of Norvasc?

Weight gain has been reported in post-marketing experience with amlodipine, although it was not a common finding in initial clinical trials. This change may be related to fluid retention (edema), which is a known and common side effect of the medication. Official documents list fluid retention as a frequently observed adverse reaction.

Q: Is it true that Norvasc can cause gum swelling or tenderness?

Official reports from post-marketing experience include the adverse reaction known as gingival hyperplasia. This is the medical term for the swelling or overgrowth of the gum tissue. It is a documented effect of amlodipine.

Q: Is Norvasc considered safe for long-term use?

Clinical data demonstrate that amlodipine's effectiveness in treating angina and lowering blood pressure is maintained over long-term dosing. For patients taking the medication once daily, official information indicates that the antihypertensive effect is sustained for at least 24 hours.

Q: How long after taking Norvasc does it start to lower blood pressure?

The concentration of amlodipine in the blood reaches its highest level (peak plasma concentration) between 6 to 12 hours after a single oral dose. This peak is associated with the drug's initial effect on blood pressure.

Q: What happens if Norvasc is discontinued suddenly?

Official patient guidance emphasizes the importance of continuing to take the medication as directed, even if the patient feels well. Regulatory guidance advises against abrupt discontinuation of amlodipine. Decisions regarding stopping treatment are determined by a healthcare provider.

Q: How long does the active ingredient in Norvasc typically stay in the body?

The time it takes for half of the drug to be eliminated from the body, known as the terminal elimination half-life, is approximately 30 to 50 hours in adults. This relatively long half-life supports the once-daily administration schedule.

Q: Is it important to keep taking Norvasc even if I do not feel any different?

Amlodipine is used to control long-term conditions like high blood pressure and angina, not cure them. Official patient information describes that treatment must be continued as directed by a healthcare provider, even when symptoms are not noticeable.

Q: Can I drink alcohol in moderation while taking Norvasc?

While an outright prohibition is not typically stated in official documents, caution is generally advised regarding alcohol consumption. Alcohol may increase the blood pressure-lowering effects of amlodipine, which could potentially lead to symptoms such as dizziness or lightheadedness.

Q: Are there common over-the-counter medicines or painkillers that interact with Norvasc?

Official interaction warnings are documented regarding the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), a class that includes some common painkillers. Studies indicate that NSAIDs may reduce the antihypertensive effect of amlodipine in certain patients and increase the risk of renal impairment.

Q: Is it better to take Norvasc in the morning or at night?

The medication is designed to be taken once daily. Official patient counseling suggests that it can be helpful to take the dose at the same time every day, such as with breakfast, dinner, or at bedtime, to establish a consistent routine for adherence.

Q: What factual guidance is available about what to do if a dose of Norvasc is missed?

Official regulatory guidance describes a standard procedure for missed doses to maintain the once-daily regimen. This guidance suggests taking the dose as soon as it is remembered, unless more than 12 hours have passed. If 12 hours have passed, the guidance is to skip the forgotten dose and proceed with the next regular dose, avoiding taking a double dose.

Q: Can Norvasc be taken for an acute, sudden episode of chest pain?

Amlodipine is used to control chest pain related to coronary artery disease when taken on a regular schedule. Official drug information specifies that it is not intended for use to immediately stop an acute, sudden episode of chest pain.

Q: Does Norvasc have any documented effects on sexual performance or desire?

Post-marketing experience with amlodipine has included reports of adverse reactions related to sexual function. Documented reports include instances of sexual dysfunction and impotence in males.

Q: What should I do if my blood pressure drops too low while using Norvasc?

Symptomatic hypotension, or low blood pressure causing symptoms, is a possible adverse reaction. Official guidance states that patients experiencing symptoms such as dizziness or lightheadedness should contact their healthcare provider or seek medical attention to determine the appropriate next steps.

How should Norvask be stored and disposed of?

Storage and Disposal Requirements for Norvasc

Norvasc (Amlodipine) tablets must be stored according to specific regulatory requirements to maintain stability.

Storage Conditions

  • Temperature: Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F).
  • Protection: Keep the medication in its original container, tightly closed, and protect it from moisture and excessive heat.
  • Child Safety: It is mandatory to keep Norvasc out of the sight and reach of children.

Disposal Instructions

Do not dispose of unused or expired Norvasc in household trash or pour it down the sink or toilet. Discard the medication through a local medicine take-back program or as instructed by a pharmacist, following all local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Norvask found in:

A-Z Index: